Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

There's nothing quite like curling up with a great book on a cold winter's day –– and with the right reading tablet, your entire library is always within reach. You can choose from the ...

Pepfar, which is estimated to have delivered lifesaving treatment to as many as 25 million people in 54 countries, faces a funding delay of as long as 180 days. By Apoorva Mandavilli The Trump ...

While more medical interventions, such as a true cure for HIV or a vaccine for the disease (which is likely still years, if not decades, away), would help, this is no longer really a problem of ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...

Galaxy Tab S10 FE and S10 FE+ are reported to feature Exynos 1580 chipset Snapdragon 7s Gen 3 SoC may power the Galaxy Tab Active 5 Pro All tablets could be offered in both Wi-Fi and 5G configurations ...

Treatment for sleep apnea aims to improve your breathing during sleep and reduce the risk of underlying health concerns. Common options include CPAP machines, oral devices, and lifestyle measures ...

Hockey served as a driving force for both Dasilva and White during their treatment — to be back out on the ice with their teammates. White, now a senior, missed her sophomore season, while ...

Samsung is working on a new rugged tablet, the Galaxy Tab Active 5 Pro, powered by the Snapdragon 7s Gen 3. The company is also working on the Galaxy Tab S10 FE and Tab S10 FE Plus, powered by the ...